China injects billions into market over March
(MENAFN) China's central bank continued to pump money into the financial system on through open market operations to balance a pre-holiday cash crisis, based on recent reports.
The financial institute used standing lending facilities, medium-term lending facilities and pledged supplementary lending, to offer more than USD228 billion for the market in March.
The processes consist of a 14-day reverse repurchase agreements (repo) priced to yield 2.4 percent and a 28-day reverse repo with a yield of 2.6 percent, each worth USD7.6 billion respectively.
According to the bank's released statements, the money injection was basically targeted at easing liquidity pressure, and support SMEs in operating sufficiently and without any problems.
The financial institute used standing lending facilities, medium-term lending facilities and pledged supplementary lending, to offer more than USD228 billion for the market in March.
The processes consist of a 14-day reverse repurchase agreements (repo) priced to yield 2.4 percent and a 28-day reverse repo with a yield of 2.6 percent, each worth USD7.6 billion respectively.
According to the bank's released statements, the money injection was basically targeted at easing liquidity pressure, and support SMEs in operating sufficiently and without any problems.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- VANTIR Launches To Transform Prop Trading With Transparency And Trust
- Brazil Edtech Market Size, Share, Trends, And Forecast 2025-2033
- Next Generation Management Corp. (OTC: NGMC) Announces Strategic Shift Toward Digital Commerce Acquisitions
- PLPC-DBTM: Non-Cellular Oncology Immunotherapy With STIPNAM Traceability, Entering A Global Acquisition Window.
- What Is The Growth Rate Of The Europe Baby Food And Infant Formula Market In 2025?
- Permissionless Data Hub Baselight Taps Walrus To Activate Data Value Onchain
Comments
No comment